Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,072 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,374
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +12.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (619)

clinicaltrialsPublishedShowing 301–350 of 852 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06609876	Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC	recruiting	N/A	108	Sun Yat-sen UniversityOTHER	1	Dec 3, 2024	clinicaltrials
NCT04602689	Fibrin Glue After ESD for High Risk Patients of Bleeding	completed	N/A	134	Seoul National University HospitalOTHER	1	Nov 29, 2024	clinicaltrials
NCT05484908